Rezultati pretrage - Gibson, Michael
- Prikaz rezultata 1 – 20 od 46
- Idi na sljedeću stranicu
-
1
-
2
Acute Urography od Roylance, John, Gibson, Michael J., Davies, Peter
Izdano 1969Tekst -
3
-
4
-
5
-
6
-
7
-
8
-
9
Atrial Conduction Slows Immediately Before the Onset of Human Atrial Fibrillation: A Bi-Atrial Contact Mapping Study of Transitions to Atrial Fibrillation od Lalani, Gautam G., Schricker, Amir, Gibson, Michael, Rostamian, Armand, Krummen, David E., Narayan, Sanjiv M.
Izdano 2012Tekst -
10
Non-small cell lung cancer cells survived ionizing radiation treatment display cancer stem cell and epithelial-mesenchymal transition phenotypes od Gomez-Casal, Roberto, Bhattacharya, Chitralekha, Ganesh, Nandita, Bailey, Lisa, Basse, Per, Gibson, Michael, Epperly, Michael, Levina, Vera
Izdano 2013Tekst -
11
Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes od Xu, Xu Steven, Moore, Kenneth, Burton, Paul, Stuyckens, Kim, Mueck, Wolfgang, Rossenu, Stefaan, Plotnikov, Alexei, Gibson, Michael, Vermeulen, An
Izdano 2012Tekst -
12
A propensity-matched analysis comparing survival after primary minimally invasive esophagectomy followed by adjuvant therapy to neoadjuvant therapy for esophagogastric adenocarcino... od Zahoor, Haris, Luketich, James D., Levy, Ryan M., Awais, Omar, Winger, Daniel G., Gibson, Michael K., Nason, Katie S.
Izdano 2014Tekst -
13
MUC2 Expression is an Adverse Prognostic Factor in Superficial Gastroesophageal Adenocarcinomas od Davison, Jon M., Ellis, Shane T., Foxwell, Tyler J., Luketich, James D., Gibson, Michael K., Kuan, Shih-Fan, Nason, Katie S.
Izdano 2013Tekst -
14
A Novel Pharmacodynamic Approach to Assess and Predict Tumor Response to the Epidermal Growth Factor Receptor Inhibitor Gefitinib in Patients with Esophageal Cancer od Altiok, Soner, Mezzadra, Heather, Jagannath, Sanjay, Tsottles, Nancy, Rudek, Michelle A, Abdallah, Nadia, Berman, David, Forastiere, Arlene, Gibson, Michael K.
Izdano 2010Tekst -
15
Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer od LaPelusa, Michael, Shen, Chan, Gillaspie, Erin A., Cann, Christopher, Lambright, Eric, Chakravarthy, A. Bapsi, Gibson, Michael K., Eng, Cathy
Izdano 2022Tekst -
16
The composition of immune cells serves as a predictor of adaptive immunity in a cohort of 50‐ to 74‐year‐old adults od Kennedy, Richard B., Simon, Whitney L., Gibson, Michael J., Goergen, Krista M., Grill, Diane E., Oberg, Ann L., Poland, Gregory A.
Izdano 2016Tekst -
17
Characterization of rubella-specific humoral immunity following two doses of MMR vaccine using proteome microarray technology od Haralambieva, Iana H., Gibson, Michael J., Kennedy, Richard B., Ovsyannikova, Inna G., Warner, Nathaniel D., Grill, Diane E., Poland, Gregory A.
Izdano 2017Tekst -
18
A Phase II Study of Bevacizumab in Combination with Docetaxel and Radiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck od Yao, Min, Galanopoulos, Nicholas, Lavertu, Pierre, Fu, Pingfu, Gibson, Michael, Argiris, Athanassios, Rezaee, Rod, Zender, Chad, Wasman, Jay, Machtay, Mitchell, Savvides, Panos
Izdano 2014Tekst -
19
Phase II Study of Erlotinib and Docetaxel with Concurrent Intensity Modulated Radiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma od Yao, Min, Lavertu, Pierre, Savvides, Panayiotis, Woods, Charles, Fu, Pingfu, Gibson, Michael, Rezaee, Rod, Zender, Chad, Wasman, Jay, Sharma, Neelesh, Machtay, Mitchell
Izdano 2016Tekst -
20
Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma od Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.
Izdano 2018Tekst